Disc Medicine Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-76.43	-46.83	-35.97	-40.84	-41.4
Depreciation & Amortization	0.39	0.3	0.19	0.32	0.29
Share-Based Compensation	5.53	2.09	0.51	0.98	0.42
Other Operating Activities	-2.95	2.19	7.74	6.82	2.16
Operating Cash Flow	-73.46	-42.25	-27.53	-32.71	-38.53
Capital Expenditures	-0.09	-0.15	-0.07	-0.02	-0.23
Investing Cash Flow	-0.09	-0.15	-0.07	-0.02	-0.23
Share Issuance / Repurchase	239.38	151.12	0.07	0.16	0.02
Debt Issued / Paid	0	0	0	14	9.95
Other Financing Activities	-	-2.14	89.86	20.08	13.25
Financing Cash Flow	239.38	148.98	89.93	34.25	23.22
Net Cash Flow	165.83	106.58	62.33	1.52	-15.54
Free Cash Flow	-73.55	-42.4	-27.6	-32.73	-38.76
Free Cash Flow Per Share	-3.30	-40.79	-31.42	-21.65	-74.95

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).